Whole genome sequencing reads every letter of your DNA, but rarely uses them all.

Whole genome sequencing reads every letter of your DNA, but rarely uses them all.
Image: Intellect (generated)

In short: While the technology can map an entire genetic blueprint, clinical practice often filters this vast data through virtual panels. This approach balances the power of comprehensive testing with the practical necessity of focusing only on genes relevant to a patient's specific symptoms, leaving the rest of the sequence stored.

Whole genome sequencing (WGS) is the most comprehensive method for analyzing an organism's genetic material. Unlike targeted tests that examine specific genes, WGS captures the complete sequence of both protein-coding and non-coding regulatory regions. In clinical settings, such as the NHS, this process typically employs short-read massively parallel sequencing. DNA is fragmented, sequenced, and then aligned against a reference to identify variations ranging from single nucleotide changes to complex structural rearrangements.

Despite the ability to read the entire genome, clinical utility is often managed through virtual panels. These digital filters restrict analysis to genes already known to be associated with a patient's clinical features. This strategy helps mitigate the significant challenge of interpreting the massive volume of variants generated by WGS, including those of uncertain significance. Because the full data is stored, clinicians may theoretically revisit the raw sequence in the future if new causal genes are discovered, though policies regarding such reanalysis are still evolving.

Beyond rare disease diagnostics, WGS has become a vital tool in oncology and public health. In cancer patients, it identifies somatic driver mutations that can guide targeted treatments, as well as germline mutations that may indicate hereditary cancer risks. For infectious diseases, it allows public health officials to track pathogens like SARS-CoV-2 and tuberculosis by identifying unique genetic fingerprints. While WGS is powerful, it faces technical hurdles, such as difficulty analyzing repetitive genomic regions or detecting DNA methylation, which often require complementary testing methods.

The field has advanced rapidly since the 2012 launch of the 100,000 Genomes Project in the UK, which aimed to integrate genomics into routine healthcare. Today, WGS is not only a diagnostic tool but a cornerstone of population genomics, helping researchers understand evolutionary history, domestication processes, and adaptive traits across diverse species. As sequencing costs decline and analytical software improves, the ability to process these complex datasets continues to expand, promising deeper insights into the biological mechanisms that shape life.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/technology-whole-genome-sequencing.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…